Skip to main content
HRTS logo

Tema Heart & Health ETF

HRTSNASDAQTemaEquity

$38.77Today:−$0.48 (−1.22%)1Y +12.68%

As of Nov 16, 2026 close

Assets (AUM)
$53.10M
Expense ratio
0.75%
Dividend yield
1.22%
Holdings
48
52-week range
$32.59$39.92
Volume (live)
-
Avg. volume (3M)
2.05K

HRTS ETF Holdings: Tema Heart & Health ETF

The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.

Total Holdings
48
Updated Nov 14, 2026
Top 10 Holdings
47.1%
Share of fund assets
Assets (AUM)
$53.10M
Total fund assets
Expense Ratio
0.75%
Annual management fee

Portfolio Allocations

Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.

Loading chart...

Top 25 of 48 HRTS Holdings by Portfolio Weight

Holdings data last updated Nov 14, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 25 positions.

Scroll to see more
HRTS ETF holdings table showing rank, ticker symbol, company name, asset type, and portfolio weight percentage, sorted by portfolio weight, last updated Nov 14, 2026.
#SymbolNameTypeWeight
1
LLY logo
LLY
Eli Lilly and CompanyStock12.61%
2
TMO logo
TMO
Thermo Fisher Scientific Inc.Stock5.40%
3
OTC:RHHBY
Roche Holding AGStock4.29%
4
MRK logo
MRK
Merck & Co., Inc.Stock4.16%
5
KOD logo
KOD
Kodiak Sciences Inc.Stock4.06%
6
BBIO logo
BBIO
BridgeBio Pharma, Inc.Stock3.72%
7
GILD logo
GILD
Gilead Sciences, Inc.Stock3.40%
8
RVMD logo
RVMD
Revolution Medicines, Inc.Stock3.31%
9
DHR logo
DHR
Danaher CorporationStock3.11%
10
JNJ logo
JNJ
Johnson & JohnsonStock3.07%
11
UNH logo
UNH
UnitedHealth Group IncorporatedStock3.03%
12
ABT logo
ABT
Abbott LaboratoriesStock2.91%
13
CPH:NOVO.B
Novo Nordisk A/SStock2.91%
14
LON:AZN
AstraZeneca PLCStock2.90%
15
VRTX logo
VRTX
Vertex Pharmaceuticals IncorporatedStock2.87%
16
SWX:NOVN
Novartis AGStock2.79%
17
CYTK logo
CYTK
Cytokinetics, IncorporatedStock2.76%
18
ISRG logo
ISRG
Intuitive Surgical, Inc.Stock2.46%
19
MCK logo
MCK
McKesson CorporationStock2.39%
20
MDT logo
MDT
Medtronic plcStock2.26%
21
SYK logo
SYK
Stryker CorporationStock2.20%
22
CNC logo
CNC
Centene CorporationStock1.98%
23
ABBV logo
ABBV
AbbVie Inc.Stock1.79%
24
EW logo
EW
Edwards Lifesciences CorporationStock1.76%
25
TYO:4578
Otsuka Holdings Co., Ltd.Stock1.43%

Source: Fund holdings disclosures. Last updated Nov 14, 2026. Data sources and methodology

Frequently Asked Questions About Tema Heart & Health ETF Holdings

What are the top holdings in HRTS?

In holdings data last updated Nov 14, 2026, HRTS's largest holdings are Eli Lilly and Company (LLY) at 12.61%, Thermo Fisher Scientific Inc. (TMO) at 5.40%, Roche Holding AG (OTC:RHHBY) at 4.29%, Merck & Co., Inc. (MRK) at 4.16% and Kodiak Sciences Inc. (KOD) at 4.06%. Together these 5 positions make up 30.5% of the fund. HRTS holds 48 securities in all; the holdings data lists the top 25 by weight.

How concentrated is HRTS's portfolio?

In holdings data last updated Nov 14, 2026, the 10 largest of HRTS's 48 positions make up 47.1% of assets. The largest single position is Eli Lilly and Company (LLY) at 12.61%. The top 25 listed positions add up to 83.6%, so the remaining 23 holdings share 16.4%. Its largest sector, Healthcare, is 100.0% of the portfolio.

What is HRTS's sector allocation?

In holdings data last updated Nov 14, 2026, HRTS's largest sector weights are Healthcare (100.0%), together 100.0% of the portfolio. It has exposure to 1 sector in total.

What countries does HRTS invest in?

In holdings data last updated Nov 14, 2026, 78.5% of HRTS's portfolio is invested in the United States, followed by Switzerland (7.8%), Denmark (4.3%) and the United Kingdom (2.9%). HRTS has exposure to 8 countries in total. By asset type the fund is 99.3% stocks and 0.7% cash.